What's new

Dr. Windi Muziasari, CEO of Resistomap, talks about how they are fighting the spread of antibiotic resistance genes by providing robust tools for monitoring.

06/23/2020

Find out which types of SARS-CoV-2 vaccines are out there and how Takara Bio is joining the fight.

06/19/2020

Researchers at Merck & Co., Inc. assess the use of rapid membrane processing for sample prep prior to PK studies in the drug development pipeline.

06/10/2020

Takara Bio USA, Inc. collaborated with bioSyntagma, Inc. and their partners to develop and validate a new high-throughput method for COVID-19 testing, and are seeking an FDA Emergency Use Authorization.

06/08/2020

Technology spotlight

Clone any insert, with any vector, at any site. In-Fusion seamless cloning technology makes it easy! Here’s how.

Constant genetic variation is the norm for influenza. Learn how a clever team of researchers overcame this challenge using In-Fusion Cloning for accurate, fast, and standardized subcloning—cutting the time from outbreak to vaccine: That's Good Science!